Drug Type Cell therapy, AAV based gene therapy |
Synonyms ASC 519, ASC-519 |
Target- |
Action- |
Mechanism Cell replacements, Gene transference(Gene transference) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia B | Preclinical | United States | 30 Jan 2022 |





